Clinical and Experimental Nephrology

, Volume 17, Issue 5, pp 708–711

ANCA-associated vasculitis: report from Korea

Review Article The Asia Pacific Meeting of Vasculitis and ANCA Workshop 2012


We investigated the clinical features of Korean patients with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) by reviewing the literature. The characteristics of AAV in Korean patients were as follows: (1) granulomatous and limited disease is prevalent in granulomatosis with polyangiitis (Wegener’s) (GPA), (2) ANCA positivity is lower in GPA (56.6–68.9 %) and eosinophilic granulomatosis with polyangiitis (EGPA) (5.9–8.3 %), whereas it is higher in microscopic polyangiitis (MPA) (69–94 %), (3) C-ANCA/proteinase 3 (PR3)-ANCA positivity is 71.5–100 % in GPA and P-ANCA/myeloperoxidase (MPO)-ANCA positivity reached 94–100 % in patients with MPA, (4) renal involvement or progression to end-stage renal disease was lower in Korean patients with GPA and EGPA than in Caucasians with GPA and EGPA (according to data provided in reports). The data provided here may need to be confirmed in large-scale studies.


ANCA Vasculitis Granulomatosis with polyangiitis (Wegener’s) Eosinophilic granulomatosis with polyangiitis Microscopic polyangiitis 

Supplementary material

10157_2012_754_MOESM1_ESM.docx (30 kb)
Supplementary material 1 (DOCX 29 kb)


  1. 1.
    Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DRW, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367:214–23.PubMedCrossRefGoogle Scholar
  2. 2.
    Kim HW, Kim JW, Im CH, Shin KC, Lee EY, Lee EB, et al. The clinicopathologic characteristics of granulomatosis with polyangiitis (Wegener’s): a retrospective study of 45 patients in Korea. Mod Rheumatol. 2012.Google Scholar
  3. 3.
    Park YB, Kim JY, Linton JA, Jung HJ, Lee SK, Shin DH. Clinicopathologic study of Wegener’s granulomatosis with special emphasis on early lesions in 10 Korean patients. Yonsei Med J. 2001;42:46–54.PubMedGoogle Scholar
  4. 4.
    Park KT, Kong IG, Han DH, Kim DW, Kim SH, Rhee CS, et al. Clinical experiences of diagnosis and treatment for Wegener’s granulomatosis. Korean J Otorhinolaryngol Head Neck Surg. 2008;51:1109–18.Google Scholar
  5. 5.
    Holle JU, Laudien M, Gross WL. Clinical manifestations and treatment of Wegener’s granulomatosis. Rheum Dis Clin North Am. 2010;36:507–26.PubMedCrossRefGoogle Scholar
  6. 6.
    Oh JS, Lee CK, Kim YG, Nah SS, Moon HB, Yoo B. Clinical features and outcomes of microscopic polyangiitis in Korea. J Korean Med Sci. 2009;24:269–74.PubMedCrossRefGoogle Scholar
  7. 7.
    Ahn JK, Hwang JW, Lee J, Jeon CH, Cha HS, Koh EM. Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea. Rheumatol Int. 2012;32:2979–86.PubMedCrossRefGoogle Scholar
  8. 8.
    Fujimoto S, Uezono S, Hisanaga S, Fukudome K, Kobayashi S, Suzuki K, et al. Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan. Clin J Am Soc Nephrol. 2006;1:1016–22.PubMedCrossRefGoogle Scholar
  9. 9.
    Lamprecht P, Holle J, Gross WL. Update on clinical, pathophysiological and therapeutic aspects in ANCA associated vasculitides. Curr Drug Discov Technol. 2009;6:241–51.PubMedCrossRefGoogle Scholar
  10. 10.
    Mahr AD, Neogi T, Lavalley MP, Davis JC, Hoffman GS, Mccune WJ, et al. Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener’s granulomatosis. Arthritis Care Res. 2008;59:884–91.CrossRefGoogle Scholar
  11. 11.
    Oh MJ, Lee JY, Kwon NH, Choi DC. Churg–Strauss syndrome: the clinical features and long-term follow-up of 17 patients. J Korean Med Sci. 2006;21:265–71.PubMedCrossRefGoogle Scholar
  12. 12.
    Kim YK, Lee KS, Chung MP, Han J, Chong S, Chung MJ, et al. Pulmonary involvement in Churg–Strauss syndrome: an analysis of CT, clinical, and pathologic findings. Eur Radiol. 2007;17:3157–65.PubMedCrossRefGoogle Scholar
  13. 13.
    Choi YH, Im JG, Han BK, Kim JH, Lee KY, Myoung NH. Thoracic manifestation of Churg–Strauss syndrome. Chest. 2000;117:117–24.PubMedCrossRefGoogle Scholar
  14. 14.
    Kang DW, Jeong IK, Kim HJ, Lee KW. Neurologic manifestations of Churg–Strauss syndrome. J Korean Neurol Assoc. 1999;17:836–40.Google Scholar
  15. 15.
    Seok JI, Bae JS, Joo EY, Min TH, Choi DC, Kim BJ. Clinical and electrophysiologic features of peripheral neuropathy in Churg–Strauss syndrome. J Korean Neurol Assoc. 2004;22:127–33.Google Scholar
  16. 16.
    Keogh KA, Specks U. Churg–Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med. 2003;115:284–90.PubMedCrossRefGoogle Scholar
  17. 17.
    Kang HJ, Park SH, Park JY, Shin YB, Kim CD, Tak WT, et al. Clinical characteristics of p-ANCA (anti-neutrophil cytoplasmic antibody)-related nephritis: a single center experience. Korean J Med. 2008;74:523–30.Google Scholar
  18. 18.
    Han S, Kwon Y, Jo S, Shin J, Cha D, Cho W, et al. Patients’ and renal survival in ANCA-associated vasculitis and glomerulonephritis. Korean J Nephrol. 1999;18:409–15.Google Scholar
  19. 19.
    Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum. 1990;33:1101–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66:222–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92.PubMedCrossRefGoogle Scholar
  22. 22.
    Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094–100.PubMedCrossRefGoogle Scholar
  23. 23.
    Sehgal M, Swanson JW, DeRemee RA, Colby TV. Neurologic manifestations of Churg–Strauss syndrome. Mayo Clin Proc. 1995;70:337–41.PubMedCrossRefGoogle Scholar
  24. 24.
    Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg–Strauss syndrome. Medicine (Baltimore). 1984;63:65–81.Google Scholar

Copyright information

© Japanese Society of Nephrology 2012

Authors and Affiliations

  1. 1.Division of Rheumatology, Department of Internal MedicineSeoul National University HospitalSeoulKorea
  2. 2.WCU Department of Molecular Medicine and Biopharmaceutical Sciences, Medical Research InstituteSeoul National University College of MedicineSeoulKorea

Personalised recommendations